Suppr超能文献

细胞膜包覆的纳米载体 - 一种用于靶向治疗的高效仿生平台。

Cell membrane coated nanocarriers - an efficient biomimetic platform for targeted therapy.

机构信息

DBT-Institute of Life Sciences, Nalco Square, Bhubaneswar, Odisha 751023, India.

Department of Pharmacy, University of Pisa, Via Bonanno Pisano, 12, 56126 Pisa, PI, Italy.

出版信息

J Control Release. 2020 Nov 10;327:546-570. doi: 10.1016/j.jconrel.2020.09.012. Epub 2020 Sep 8.

Abstract

Targeted therapy approaches have become the core of modern translational science and as an intriguing field, it is the solution of the conventional drug delivery problems that were once unanswered. Traditional methods of delivering drugs and therapeutics faced issues of solubility, sustained release, not enough amount getting through the diseased site, for e.g a tumor. Various formulations of liposomes, polymers, dendrimers, etc have succeeded and made their way for clinical trials trying to enhance the pharmacokinetic and biodistribution of the drug. Many stealth coatings that include hydrophilic polymers (PEG, chitosan, polyacrylamides, etc) can act as a covering around the nanoparticle that can shield the surface from aggregation, opsonization and evade immune system, thus considered in Generally Recognized as Safe (GRAS) category. Several other polymers such as poly-2-oxazoline, polyethylene oxide, PEG-based surfactant (polysorbate-80), and zwitterionic phospholipids have also been tested for their antifouling properties. However, the polymer coating approach requires labor-intensive procedures and conjugation chemistries that often fail in mice model. Besides, due to immunogenicity and allergic reactions evoked by the PEG-coated nanoparticles, there was an urge to find biomimicking materials that can prove better as shielding agents which paved the way for cell membrane coated nanoparticles (CMCNPs) to come into the limelight. CMCNPs consist of a nanoparticle inner core covered by cell membrane that can be implicated in targeted drug delivery approaches, photothermal therapy, diagnosis or imaging making it a powerful theranostic tool. In this review, mode of preparation of CMCNPs, different sources of cell membranes (RBCs, WBCs, platelets, cancer cells, stem cells with some other unconventional sources) and nanoparticle cores that are employed have been thoroughly emphasized. In addition to this, advancements and limitations with respect to this newly emerging field have been focussed.

摘要

靶向治疗方法已成为现代转化科学的核心,作为一个引人入胜的领域,它解决了传统药物输送方法曾经无法解决的问题。传统的药物和疗法输送方法面临着溶解度、持续释放、无法足够数量到达病变部位等问题,例如肿瘤。各种脂质体、聚合物、树枝状聚合物等的制剂已经成功并为临床试验铺平了道路,试图增强药物的药代动力学和生物分布。许多包括亲水性聚合物(PEG、壳聚糖、聚丙烯酰胺等)的隐形涂层可以作为纳米颗粒的覆盖物,防止表面聚集、被调理和逃避免疫系统,因此被认为是一般公认安全(GRAS)类别。其他几种聚合物,如聚-2-恶唑啉、聚氧化乙烯、基于 PEG 的表面活性剂(聚山梨酯-80)和两性离子磷脂,也因其抗污性能而得到了测试。然而,聚合物涂层方法需要劳动密集型的程序和缀合化学,这些方法在小鼠模型中经常失败。此外,由于 PEG 涂层纳米颗粒引起的免疫原性和过敏反应,人们迫切需要寻找可以更好地作为屏蔽剂的仿生材料,这为细胞膜涂层纳米颗粒(CMCNPs)的出现铺平了道路。CMCNPs 由纳米颗粒内核组成,内核被细胞膜覆盖,可以用于靶向药物输送方法、光热治疗、诊断或成像,使其成为一种强大的治疗诊断工具。在这篇综述中,CMCNPs 的制备方式、细胞膜的不同来源(RBCs、WBCs、血小板、癌细胞、干细胞以及一些其他非常规来源)和所使用的纳米颗粒核心都得到了深入强调。除此之外,还重点关注了这个新兴领域的进展和局限性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验